Q2 2023 · 13F-HR
Artia Global Partners LPholdings as filed
Filed 2023-08-14 · accession 0001937964-23-000005
$290.1M
Reported value
34
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670100205 | NVO | NOVO-NORDISK A S | $55.2M | 19.0% | 340,906 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $38.0M | 13.1% | 329,200 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $18.1M | 6.24% | 46,438 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $14.9M | 5.13% | 52,275 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $13.7M | 4.71% | 190,752 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $12.2M | 4.22% | 90,821 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $10.3M | 3.55% | 84,719 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $10.3M | 3.53% | 543,358 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $9.8M | 3.40% | 51,175 | Common | SOLE |
| 46583P102 | — | IVERIC BIO INC | $9.6M | 3.32% | 244,861 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $9.4M | 3.23% | 102,940 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $8.8M | 3.05% | 77,162 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $8.8M | 3.04% | 465,465 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $8.3M | 2.86% | 824,363 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $7.6M | 2.62% | 16,193 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $6.8M | 2.34% | 78,465 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $6.4M | 2.22% | 18,314 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $6.3M | 2.18% | 87,848 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $6.2M | 2.14% | 383,580 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $4.2M | 1.46% | 45,000 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $4.0M | 1.38% | 37,108 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $3.1M | 1.07% | 112,340 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $3.0M | 1.05% | 15,971 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $2.7M | 0.92% | 5,088 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $2.6M | 0.91% | 41,600 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.9M | 0.66% | 38,555 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $1.9M | 0.64% | 169,277 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.8M | 0.62% | 100,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $1.5M | 0.50% | 6,905 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $770,659 | 0.27% | 45,253 | Common | SOLE |
| 941848103 | WAT | WATERS CORP | $758,306 | 0.26% | 2,845 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $558,671 | 0.19% | 25,452 | Common | SOLE |
| 617760202 | MOR2 | MORPHOSYS AG | $324,938 | 0.11% | 43,499 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $185,582 | 0.06% | 95,170 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.